Prosecution Insights
Last updated: April 19, 2026

Deutsches Krebsforschungszentrum

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18550130 IMMUNE ENHANCERS LANKFORD JR, LEON B 1657 Final Rejection Sep 11, 2023
17439921 EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS BURKHART, MICHAEL D 1638 Final Rejection Sep 16, 2021
17279914 LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS WESTERBERG, NISSA M 1618 Non-Final OA Mar 25, 2021

Managing Deutsches Krebsforschungszentrum's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month